Screener
Kymera Therapeutics KYMR Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Kymera Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Kymera Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333849
FAQ
- What is Kymera Therapeutics's net margin?
- Kymera Therapeutics (KYMR) reported net margin of -285.3% in Q2 2026.
- How has Kymera Therapeutics's net margin changed year-over-year?
- Kymera Therapeutics's net margin increased by 53.7% year-over-year, from -616% to -285.3%.
- What is the long-term trend for Kymera Therapeutics's net margin?
- Over 5 years (2020 to 2025), Kymera Therapeutics's net margin has grown at a 42.7% compound annual growth rate (CAGR), from -134% to -794.1%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Kymera Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude